July 2023
169 articles-
Jul 31 · 02:26Biotechnology Daily
Zentalis showcases ovarian cancer data that will take WEE1 to phase 3
-
Jul 31 · 02:25Biotechnology Daily
After lung cancer fails, Roche's faith in TIGIT rewarded as tiragolumab shows signs of life in liver cancer
-
Jul 31 · 02:24Biotechnology Daily
Regeneron's Opdualag rival records double the historical response rate in melanoma
-
Jul 31 · 02:22Biotechnology Daily
'Quite science fiction': Brain-spine interface system helps man with paralysis walk again
-
Jul 31 · 02:20Bio Business News
Illumina shareholders vote in one Carl Icahn nominee over current chairman, reject executive pay proposal
-
Jul 31 · 02:19Bio Business News
Boston Scientific nixes $230M acquisition of stent maker M.I.Tech, citing regulatory roadblocks
-
Jul 31 · 02:17Bio Business News
Medtronic acquires insulin patch pump maker EOFlow for $738M amid new MiniMed rollout
-
Jul 31 · 02:16Bio Business News
BenevolentAI makes deep cuts after midphase flop, laying off 180 and shrinking lab footprint
-
Jul 28 · 02:22Biotechnology Daily
Mirati's long wait for next lung cancer med ends in phase 3 failure
-
Jul 28 · 02:21Biotechnology Daily
THREAD signs on with Allucent to launch DCTs for smaller biotechs
-
Jul 28 · 02:20Biotechnology Daily
FDA needs more time for Sarepta's DMD gene therapy—spurring a deja vu of Exondys 51
-
Jul 28 · 02:18Biotechnology Daily
Flipping the script on a cancer pathway to regrow nerves and protect the heart
-
Jul 28 · 02:17Bio Business News
PD-1 inhibitor R&D tapering off as newer oncology molecules capture attention: IQVIA
-
Jul 28 · 02:15Bio Business News
Annexon's eye disease med improved vision in a phase 2 trial but flunked the primary goal. The CEO was thrilled
-
Jul 28 · 02:04Bio Business News
Cepheid taps former Philips North America head Vitor Rocha as president
-
Jul 28 · 02:03Bio Business News
From megaround to $16M buyout: Apexigen limps to exit, accepting Pyxis' bid 300 days after going public
-
Jul 28 · 00:42Market Watch
Apple stock rises into record territory, heads for longest-ever monthly win streak to start a year
-
Jul 27 · 02:16Biotechnology Daily
2 small biotechs morph to work on oncology together
-
Jul 27 · 02:15Biotechnology Daily
ICU Medical faces Class I recall of infusion system replacement batteries
-
Jul 27 · 02:14Biotechnology Daily
ASGCT 2023: Tessera, Tune, Prime Medicine and more present new preclinical data
-
Jul 27 · 02:12Biotechnology Daily
Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target
-
Jul 27 · 02:11Bio Business News
ElevateBio takes fundraising crown with $401M series D, adds Novo Nordisk to growing army of partners
-
Jul 27 · 02:09Bio Business News
PTC pulls back from gene therapy, lays off staff after phase 3 fail but still hopes for rare disease approval
-
Jul 27 · 02:07Bio Business News
Bayer's acting BD chief lobbies for the job the only way he knows how: by making deals